Treatment of obsessive-compulsive spectrum disorders with SSRIs
The DOI matches its Crossref record.
Abstract
Background Obsessive-compulsive spectrum disorders (OCSDs) are now recognised as distinct diagnostic entities related to obsessive-compulsive disorder (OCD). The features of OCSDs and OCD overlap in many respects including demographics, repetitive intrusive thoughts or behaviours, comorbidity, aetiology and preferential response to anti-obsessional drugs such as the selective serotonin reuptake inhibitors (SSRIs). Method Literature was reviewed and preliminary data from various studies were re-examined to assess the relationship between compulsivity and impulsivity, and between OCD and OCSDs. Results OCSDs include both compulsive and impulsive disorders and these can be viewed as lying at opposite ends of the dimension of risk avoidance. Compulsiveness is associated with increased frontal lobe activity and increased serotonergic activity, while impulsiveness is associated with reduced activity of these variables. Neural circuits affected by serotonergic pathways have been identified and pharmacological challenge of OCSD patients with serotonin receptor agonists have supported the involvement of serotonergic processes. Conclusions SSRIs such as fluvoxamine have established efficacy in OCD and preliminary studies indicate that they are also effective in OCSDs. The features of three specimen OCSDs –body dysmorphic disorder, pathological gambling and autism – and their treatment with SSRIs are reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Opponent interactions between serotonin and dopamine
Daw, N. D., Kakade, S., & Dayan, P. (2002) · Neural Networks · doi:10.1016/s0893-6080(02)00052-7 · Cited by 844
Serotoninergic regulation of emotional and behavioural control processes
Cools, R., Roberts, A. C., & Robbins, T. W. (2008) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2007.10.011 · Cited by 656
“…hand, the anxiety-reducing effects of the benzodiazepines, which reduce 5-HT transmission [1], and on the other hand, the ameliorative effects of the long-term use of selective serotonin reuptake inhibitors (SSRIs), which increase 5-HT transmission (Box 1), in depression and panic disorder [2,3].”
Frontal lobe dysfunction in pathological gambling patients
Cavedini, P., Riboldi, G., Keller, R., D’Annucci, A., & Bellodi, L. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01227-6 · Cited by 418
Quality of life and disability in patients with obsessive-compulsive disorder
Bobes, J., González, M. P., Bascarán, M. T., Arango, C., Sáiz, P. A., & Bousoño, M. (2001) · European Psychiatry · doi:10.1016/s0924-9338(01)00571-5 · Cited by 270
Eating disorders: clinical features and pathophysiology
Klein, D. A., & Walsh, B. T. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.02.009 · Cited by 164
Metadata
- Authors
- Hollander, E.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 1998-08
- Volume
- 173
- Issue
- S35
- Pages
- 7-12
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W5418449
- Cited by
- 132
- References
- 0
- FWCI
- 11.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of obsessive-compulsive spectrum disorders with SSRIs. https://app.cochat.ai/papers/10.1192/s0007125000297845
- The paper
- Hollander, E. (1998). Treatment of obsessive-compulsive spectrum disorders with SSRIs. British Journal of Psychiatry. https://doi.org/10.1192/s0007125000297845
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.